Muthusamy Shanmugam
HEAD OF R&D, COO-NOVITIUM OPS at ANI Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ANI Pharmaceuticals Inc., 3 years.
ANI Pharmaceuticals Inc.
Director · HEAD OF R&D, COO-NOVITIUM OPS
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +14,362 | — | — |
| Feb 12, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +9,574 | — | — |
| Jul 18, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −2,743 | $62.00 | $170,066 |
| Jul 17, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −14,257 | $63.16 | $900,472 |
| Jul 16, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −22,000 | $64.27 | $1,413,940 |
| Jul 15, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −11,000 | $63.38 | $697,180 |
| Jun 21, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −20,000 | $58.90 | $1,178,000 |
| Jun 20, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −11,447 | $59.86 | $685,217 |
| Jun 18, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −10,607 | $60.76 | $644,481 |
| Jun 17, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −7,946 | $61.41 | $487,964 |
| May 20, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −12,855 | $61.81 | $794,568 |
| May 17, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −5,836 | $62.09 | $362,357 |
| May 16, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −16,459 | $63.84 | $1,050,743 |
| May 15, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −14,850 | $65.86 | $978,021 |
| Apr 19, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −16,809 | $65.17 | $1,095,443 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.